24/10/2014 13:55:39 Free Membership Login

The Pharmaceutical Market: India

Date : 11/29/2012 @ 12:11AM
Source : PR Newswire (US)

The Pharmaceutical Market: India

The Pharmaceutical Market: India

NEW YORK, Nov. 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Pharmaceutical Market: India

http://www.reportlinker.com/p0203061/The-Pharmaceutical-Market-India.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.

Specialised intelligence on OTCs, generics, biologics and biosimilars.

Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.

A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

TABLE OF CONTENTS

EXECUTIVE SUMMARY 1

Snapshot: Strategic Espicom Analysis 2

Snapshot: Key Data Projections3

MACROENVIRONMENT 4

POLITICAL 4

ECONOMIC5

Projections 5

LEGAL 6

Background to Pharmaceutical Patents 6

Mashelkar Committee Report, December 2006 6

The Patents (Amendments) Bill, 2005 7

Compulsory Licensing 7

Pre- & Post-Grant Opposition 8

Mailbox Applications 8

Other Issues 9

The Patents (Amendment) Rules, 2006 9

Previous Patents Act Amendments and Exclusive Marketing Rights 10

Challenges and Patent Decisions in the Indian High Courts 10

Novartis Once Again Challenges the Indian Patents Act 10

Bayer's Nexavar Patent Challenged by Compulsory Licence Application 11

US Special 301 Report - India Remains on Priority Watch List 12

DEMOGRAPHIC 12

Population 12

Demographic Indicators 14

Births 14

Deaths 14

Infant Mortality 14

Life Expectancy at Birth 14

EPIDEMIOLOGY 16

DISEASE BURDEN 16

Leading Causes of Mortality 16

DISEASE PREVALENCE17

Communicable Diseases 17

HIV/AIDS 19

Leprosy20

Tuberculosis20

Vector Borne Diseases 21

Non-Communicable Diseases 21

Blindness 21

Cancer 21

Diabetes, Cardiovascular Disease and Stroke22

National Rural Health Mission22

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 24

ORGANISATION 24

Public Sector 24

Department of Health and Family Welfare 24

Department of AYUSH 25

Private Sector 25

Health Insurance 26

EXPENDITURE 27

Projections 27

Latest Figures 28

INFRASTRUCTURE 29

Hospital Infrastructure29

Private Hospitals and Clinics30

Apollo Hospitals Group 30

Fortis Healthcare 30

Max Healthcare 30

Wockhardt Hospitals30

Other Commercial Providers 31

Ambulatory Infrastructure31

Primary Care 31

First Aid and Disaster Relief 32

WORKFORCE 32

Projections 32

Latest Figures 33

REGULATORY AFFAIRS 35

NATIONAL AUTHORITY 35

REGULATORY DEVELOPMENTS 36

New Drug Advisory Committees36

MARKETING REGISTRATION 37

DGCI Set to Co-ordinate Drug Approvals 38

PROMOTION 38

PRICING 39

Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006 39

Draft National Pharmaceuticals Pricing Policy, 2011 40

DISTRIBUTION CHANNELS 42

Medical Stores Organisation 42

Pharmacy Chains 42

Apollo Pharmacy 42

Guardian Lifecare 42

Religare Wellness 42

98 4 42

MARKET ANALYSIS 43

SIZE 43

Projections 43

Historical Figures 46

Current Structure 47

PRODUCT DEVELOPMENT 48

Traditional Indian Medicines 49

MANUFACTURING 51

TRADE52

Exports 52

Imports 54

Balance of Trade 58

COMPETITION 59

Foreign Direct Investment in the Pharmaceutical Industry under Review 59

TRADE ASSOCIATIONS 60

TRADE FAIRS 60

Bangalore Bio 201260

India Chem 2012 60

Pharma World EXPO 60

COMPANY INTELLIGENCE61

Foreign Private Producers 61

Abbott 61

Actavis 61

Bayer Healthcare 61

Daiichi Sankyo 62

GlaxoSmithKline 62

Mylan62

Pfizer India63

Reckitt Benkiser63

Sanofi63

Local Private Producers 64

Alembic Ltd 64

Aurobindo Pharma66

Cipla Ltd 68

Claris Lifesciences71

Dr Reddy's Laboratories Ltd 72

Glenmark Pharmaceuticals 75

Jubilant Life Sciences78

Lupin Limited 79

Natco Pharma 82

Orchid Chemicals & Pharmaceuticals Ltd 84

Piramal Healthcare 87

Ranbaxy Laboratories 89

Strides Arcolab 92

Sun Pharma 94

Torrent Pharmaceuticals97

Wockhardt Ltd 99

Zydus Cadila 102

COMPETITIVE STRATEGIES 106

Recent Acquisitions & Divestitures 106

Agreements 106

BIOLOGICS & BIOSIMILARS 108

COMPETITION 108

Company Intelligence108

Avesthagen 108

BCG Vaccine Laboratory, Chennai109

Biocon109

Cipla 111

Claris Lifesciences 111

Dr Reddy's111

Glenmark Pharmaceuticals 112

Lupin 112

Panacea Biotec 113

Ranbaxy/Daiichi Sankyo 113

Wockhardt 114

Zydus Cadila 114

COMPETITIVE STRATEGIES 115

CONCLUSIONS: OPPORTUNITIES & CHALLENGES 116

Strategic Espicom Analysis 116

MACROENVIRONMENT 116

EPIDEMIOLOGY 116

HEALTHCARE 117

REGULATORY AFFAIRS 117

PRICING & REIMBURSEMENT 117

DISTRIBUTION CHANNELS 118

MARKET 118

COMPETITION 118

OTC PHARMACEUTICALS 118

GENERICS 118

BIOLOGICS & BIOSIMILARS 119

Radar & SWOT Analysis 121

DIRECTORY 122

GOVERNMENT ORGANISATIONS 122

PHARMACEUTICAL COMPANIES 123

TRADE ASSOCIATIONS 123

List of Tables

Espicom Analysis of the Pharmaceutical Market, 2012 2

Key Data Projections, 2012-2017 3

Political Landscape, 2012 4

Regional Ranking of Projected Economies, 2017 5

Projected Economy, 2012-2017 5

Regional Ranking of Projected Demographics, 2017 13

Projected Demographics, 2012-2017 13

Summary of Demographic Data 15

Demographic Indicators, 2000-2010 15

Deaths from Communicable Diseases, 2004-2009 16

Reported Incidence of Communicable Diseases, 2005-2009 17

Reported Incidence of Vaccine Preventable Diseases, 2008-2010 18

Regional Ranking of Projected Health Expenditure, 2017 27

Projected Health Expenditure, 2012-2017 27

Health Expenditure, 2011 28

Regional Ranking of Projected Physicians, 2017 32

Projected Physicians, 2012-2017 33

Doctors Registered with State Medical Councils, 2007-2010 33

Regional Ranking of Projected Pharmaceutical Markets, 2017 43

Asia Pacific Market Share, 2017 44

Projected Pharmaceutical Market at Retail Prices, 2012-2017 45

Historical Pharmaceutical Market at Retail Prices, 1995-2010 (US$ Million)46

Pharmaceutical Exports by Category, 1995-2010 (US$000s) 52

Pharmaceutical Exports by Country/Region, 2010 (US$000s) 53

Pharmaceutical Imports by Category, 1995-2010 (US$000s) 54

Imports of Raw Materials by Country/Region, 2010 (US$000s) 55

Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 56

Imports of Medicaments by Country/Region, 2010 (US$000s) 57

Balance of Pharmaceutical Trade, 1995-2010 (US$000s) 58

Foreign Acquisitions of Indian Pharmaceutical Companies, 2007-2011 59

Alembic: Financial Results, 2007-2011 64

Alembic: Manufacturing Facilities 65

Aurobindo Pharma: Financial Results, 2007-2011 66

Aurobindo Pharma: Manufacturing Facilities 67

Cipla: Financial Results, 2007-2011 68

Cipla: Manufacturing Facilities 70

Dr Reddy's: Financial Summary, 2007-2011 73 Dr Reddy's: Manufacturing Facilities 74

Glenmark: Financial Results, 2007-2011 75

Glenmark: Manufacturing Facilities 77

Jubilant Life Sciences: Financial Results, 2010-2011 78

Lupin: Financial Results, 2007-2011 80

Lupin: Manufacturing Facilities 81

Natco Pharma Financial Results, 2007-2011 82

Orchid: Financial Results, 2007-2011 85

Orchid's Top-10 Brands 85

Orchid: Manufacturing Facilities 86

Piramal Healthcare: Financial Results, 2007-2011 87

Piramal Healthcare: Manufacturing Facilities 88

Ranbaxy: Financial Results, 2006-2010 89

Ranbaxy: Manufacturing Facilities 91

Strides: Financial Results, 2006-2010 92

Sun Pharma: Financial Results, 2007-2011 94 Sun Pharma: Manufacturing Facilities 96

Torrent Pharma: Financial Results, 2007-2017 97

Wockhardt: Financial Results, 2006-2011 99 Wockhardt Manufacturing Facilities 101

Zydus Cadila: Financial Results, 2007-2011 103

Zydus Cadila: Manufacturing Facilities 105

Biocon: Financial Results, 2007-2011 110

Panacea Biotec: Financial Results, 2007-2011 113

Espicom Analysis of the Pharmaceutical Market, 2012 120

SWOT Analysis of the Pharmaceutical Market, 2012 121

List of Charts

Population by Age Group (%)12

Regional Comparison of Top 5 Projected Pharmaceutical Markets at Retail Prices, 2017 44

Regional Comparison of Projected Pharmaceutical Market Share, 2017 45

Historical Pharmaceutical Market at Retail Prices, 1995-2010 47

Pharmaceutical Exports, 1995-2010 (US$ Millions) 52

Pharmaceutical Imports, 1995-2010 (US$ Millions) 54

Pharmaceutical Imports by Country/Region, 2010 (%) 55

Balance of Pharmaceutical Trade, 1995-2010 (US$ Millions) 58

Radar Graph of the Pharmaceutical Market, 2012 121

To order this report:

Pharmaceutical Industry: The Pharmaceutical Market: India

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright 2012 PR Newswire



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 in 141024 13:55